E.g., 03/28/2017
E.g., 03/28/2017

bioMérieux’s VIDAS® B•R•A•H•M•S PCT™ becomes the first FDA-cleared procalcitonin assay as an aid for antibiotic stewardship in respiratory infections and sepsis

24 February, 2017

bioMérieux, a world leader in the field of in vitro diagnostics, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the expanded use of VIDAS® B•R•A•H•M•S PCT™, an automated assay measuring procalcitonin (PCT) levels, to help clinicians make important decisions regarding the optimal use of antibiotics in two common clinical situations: lower respiratory tract infections (LRTI) and sepsis.

bioMérieux – Fourth-Quarter 2016 Business Review

19 January, 2017

Marcy l'Étoile, January 19, 2017 – bioMérieux, a world leader in the field of in vitro diagnostics, today released its business review for the twelve months ended December 31, 2016.

bioMérieux and Banyan Biomarkers Partner to Develop, Validate and Market Blood-Based Biomarkers for Traumatic Brain Injury

19 January, 2017

bioMérieux, a world leader in the field of in vitro diagnostics and Banyan Biomarkers, an innovative biomarkers company developing blood tests capable of diagnosing traumatic brain injuries (TBI), announced today that they have entered into a partnership.

Year End Holiday Shipping Schedule

15 November, 2016

Please be advised that bioMérieux sites in Durham, St. Louis, Louisville and Lombard will be closed on Thursday, November 24 and Friday, November 25 as well as Monday, December 26 and Tuesday, December 27 in observance of the upcoming holidays.

Veteran's Day Shipping Schedule

03 November, 2016

As part of our commitment to providing you more efficient and better services we will be upgrading our ERP system, SAP, on Friday, November 11, 2016.

bioMérieux – Business Review for the nine months ended September 30, 2016

20 October, 2016

bioMérieux, a world leader in the field of in vitro diagnostics, today released its business review for the nine months ended September 30, 2016.

FilmArray® Respiratory Panel EZ is CLIA waived by the FDA

11 October, 2016

October 11, 2016 – bioMérieux, a world leader in the field of in vitro diagnostics, announced that BioFire Diagnostics, LLC, its molecular biology affiliate, received U.S. Food and Drug Administration (FDA) 510(k) clearance and Clinical Laboratory Improvement Amendments (CLIA) waiver for the FilmArray® Respiratory Panel EZ (RP EZ).

Shipping Delays Due to Hurricane Matthew

06 October, 2016

Due to the impact of Hurricane Matthew the southeast and mid-Atlantic delivery services by national carriers has been interrupted.

Growing Global 2016

19 September, 2016

Foreign-Direct Investment Growing Global is the St. Louis region's premier event for the international business community.

Education, Awareness, Celebration of Sepsis Families and the Outstanding Contributions to Sepsis Early Detection: bioMérieux, Inc. Releases National Sepsis Month 2016 Activities

14 September, 2016

Back-to-back events and symposia making National Sepsis Awareness Month 2016 the most eventful since Sepsis Month was launched 5 years ago!

Pioneering diagnostics